Objective: Coronavirus disease-2019 (COVID-19) was
declared a pandemic in March 2020. As the number of cases increased,
the infection emerged as a multi-systemic disease. Respiratory, cardiac,
hepatic, urinary, circulatory, gastrointestinal systems and finally skin
may be the target organs of COVID-19. The aim of this study was to
evaluate the cutaneous signs of COVID-19 and their effect on the patients’
prognosis. Material and Methods: A total of 192 hospitalized
COVID-19 cases, between May 2021 to July 2021 were included in the
study. The length of stay (LoS) of the patients were recorded. Hospitalization
and discharge decisions and all treatments of the patients were
determined at the discretion of the treating physician according to the
pandemic guidelines of the Ministry of Health. Fever, fatigue, cough,
dyspnea, myalgia, anosmia, and headache were considered COVID-19
symptoms. Results: Dermatological manifestations were seen in 10
cases. LoS in the group with dermatological findings was shorter than
the group without dermatological findings and the difference was statistically
significant between the groups. Discharge of the patients was
the endpoint of the study. Conclusion: Our multicenter study suggests
that patients with cutaneous findings usually do not have classical
symptoms for COVID-19 and have a shorter LoS
|
